Latest News and Press Releases

SAN DIEGO, CA--(Marketwired - Sep 1, 2015) -  Aegis Therapeutics LLC announced today that it has been awarded its first Russian patent providing expanded coverage for non-invasive delivery of...

SAN DIEGO, CA--(Marketwired - Aug 27, 2015) - Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 9,114,069 titled "Antibacterial Compositions for Drug Administration"...

SAN DIEGO, CA--(Marketwired - Aug 11, 2015) - Aegis Therapeutics LLC announced today that it has been awarded foreign patents providing expanded coverage for non-invasive delivery of triptan...

SAN DIEGO, CA--(Marketwired - Feb 18, 2015) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,927,497 providing broad coverage for non-invasive delivery of...

SAN DIEGO, CA--(Marketwired - Nov 12, 2014) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,883,728, providing for highly efficient delivery of drugs to the...

SAN DIEGO, CA--(Marketwired - Oct 7, 2014) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,846,044, dramatically broadening its patent franchise to cover all...

SAN DIEGO, CA--(Marketwired - Aug 5, 2014) - Aegis announced today that it is offering an exclusive license to develop, commercialize, and sell its patented non-invasive exenatide metered nasal...

SAN DIEGO, CA--(Marketwired - Jul 8, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its U.S. Patent No. 8,772,231 providing dramatically stabilized insulin formulations...

SAN DIEGO, CA--(Marketwired - Mar 12, 2014) - Aegis Therapeutics LLC's Intravail® technology has been successfully formulated with phenylephrine in compressed tablets, dramatically improving...

SAN DIEGO, CA--(Marketwired - Feb 5, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon Aegis'...